Image quality and cancer visibility of T2-weighted Magnetic Resonance Imaging of the prostate at 7 Tesla
✍ Scribed by Vos, E. K.; Lagemaat, M. W.; Barentsz, J. O.; Fütterer, J. J.; Zámecnik, P.; Roozen, H.; Orzada, S.; Bitz, A. K.; Maas, M. C.; Scheenen, T. W. J.
- Book ID
- 125344843
- Publisher
- Springer
- Year
- 2014
- Tongue
- English
- Weight
- 688 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0938-7994
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Proton magnetic resonance spectroscopic imaging (MRSI) of the prostate has been described at 1.5 T and 3 T as a means of localizing prostate cancers with high sensitivity and specificity. This technique could be improved by increasing the field strength further; however, it has not been
## Abstract Magnetic resonance spectroscopic imaging (MRSI) has proven to be a powerful tool for the metabolic characterization of prostate cancer in patients before and following therapy. The metabolites that are of particular interest are citrate and choline because an increased choline‐to‐citrat